Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Patch testing for corticosteroid allergy.

Rokea el-Azhary1, Erin Warshaw, Kalman L Watsky

  • 1Mayo Clinic, Rochester, MN, USA.

Dermatitis : Contact, Atopic, Occupational, Drug
|October 12, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing observational skills through art at Yale.

Journal of the American Academy of Dermatology·2025
Same author

Variations in Anatomic Locations of Squamous Cell Carcinoma Stratified by Histologic Risk: A Single-Center Retrospective Study.

International journal of dermatology·2025
Same author

Irwin M. Braverman, MD, and paintings in the Yale Center for British Art.

Clinics in dermatology·2024
Same author

Hot Tub Dermatitis: Allergic Contact Dermatitis to Potassium Peroxymonosulfate.

Dermatitis : contact, atopic, occupational, drug·2024
Same author

High-risk adverse drug reactions: consideration of limited dialysis therapy for toxic epidermal necrolysis (TEN).

International journal of dermatology·2023
Same author

Going Green and Adhesive-Free: Snap-in Reusable Menstrual Pads for Tampon and Pad Intolerance.

Dermatitis : contact, atopic, occupational, drug·2023
Same journal

The Toxin of the Year: Airborne PM<sub>2.5</sub>.

Dermatitis : contact, atopic, occupational, drug·2026
Same journal

Eyelid Dermatitis: A 5-Year Retrospective Review from a Metropolitan Contact Dermatitis Clinic.

Dermatitis : contact, atopic, occupational, drug·2026
Same journal

<i>Letter:</i> Anogenital Dermatitis Rarely Occurs in Isolation: Disease Distribution and Delays in Patch Testing.

Dermatitis : contact, atopic, occupational, drug·2026
Same journal

Practical Techniques: Photopatch Testing.

Dermatitis : contact, atopic, occupational, drug·2026
Same journal

Assessment and Clinical Management of Patients With Atopic Dermatitis Undergoing Patch Testing: Recommendations From an International Electronic Delphi Consensus.

Dermatitis : contact, atopic, occupational, drug·2026
Same journal

Digital Image Superimposition for Identifying Delayed Patch Test Reactions: A Clinical Pearl.

Dermatitis : contact, atopic, occupational, drug·2026
See all related articles

Contact allergy to topical corticosteroids is a common dermatologic complication, with hydrocortisone being the most frequent allergen. Newer treatments may decrease corticosteroid allergy incidence.

Area of Science:

  • Dermatology
  • Allergology
  • Immunology

Background:

  • Contact allergy to topical corticosteroids emerged as a significant complication in dermatologic treatments during the 1990s.
  • Classification of corticosteroids based on chemical structures aids in predicting cross-reactions.
  • Hydrocortisone's ubiquitous use in over-the-counter products makes it the predominant allergen.

Purpose of the Study:

  • To explore strategies for detecting allergens in patients with suspected topical corticosteroid allergy.
  • To provide recommendations for allergen substitution in managing corticosteroid allergy.
  • To gather expert opinions on addressing topical corticosteroid contact allergy.

Main Methods:

  • Expert consultation and opinion gathering from dermatologists.

Related Experiment Videos

  • Review of existing knowledge on corticosteroid classification and cross-reactivity.
  • Discussion of diagnostic approaches for contact allergy.

    • Main Results:

    • Hydrocortisone identified as the most common allergen due to widespread use.
    • Chemical grouping of corticosteroids is a useful tool for identifying potential cross-reactions.
    • Awareness and alternative therapies may reduce corticosteroid allergy rates.

    Conclusions:

    • Contact allergy to topical corticosteroids is a recognized issue, with hydrocortisone being a primary concern.
    • Expert insights are valuable for developing strategies to detect and manage corticosteroid allergy.
    • Emerging immunomodulating agents offer potential alternatives, possibly reducing future allergy incidence.